Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapies

Affiliations

• ¹ Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Canada.
• ² Institute of Cancer Policy, King's College London, London, UK; King's Health Partners Comprehensive Cancer Centre, London, UK.
• ³ Kingston General Hospital Research Institute, Kingston.
• ⁴ Department of Oncology, Queen's University, Kingston, Canada; Department of Public Health Sciences, Queen's University, Kingston, Canada. Electronic address: boothc@kgh.kari.net.